WV.gov
Agency Header

Preferred Drug List

The Preferred Drug List is a medication list recommended to the Bureau for Medical Services by the Medicaid Pharmaceutical and Therapeutics (P & T) Committee and approved by the Secretary of the Department of Health and Human Resources, as authorized by West Virginia Code §9-5-15.  The drugs which are indicated as "preferred" have been selected for their clinical significance and overall efficiencies.

All Medicaid-covered drugs noted as "non-preferred" will continue to be available through the prior authorization process.  Some select preferred drugs may require prior authorization, as noted.  A three-day emergency supply of prior-authorized drugs can be dispensed by a pharmacy until authorization is completed.

Please note:  The PDL only addresses certain drug classes.  Some classes of drugs will not be reviewed for preferential agents because of no or limited cost savings.  Therefore, drugs which have historically been covered by Medicaid and are not listed on the Preferred Drug List will contiue to be covered.

New drugs introduced into the marketplace in therapeutic classes that have been reviewed will be considered non-preferred until the annual review of the particular therapeutic class.  Exceptions to this policy will be made for drugs which the FDA has given priority status.

BMS contracts with Magellan Medicaid Administration, Inc. (MMA) for assistance with PDL development and clinical support.  BMS is also a member of the Sovereign States Drug Consortium (SSDC), the only state administered multi-state supplemental rebate pool.   For more information about MMA or SSDC, please refer to their websites at, http://www.rxssdc.org respectively.

PDL Frequently Asked Questions


P & T Committee Mission Statement

The West Virginia Medicaid Pharmaceutical and Therapeutics Committee is committed to:

  • Objectively recommending drugs for inclusion on the WV Preferred Drug List (PDL) that are effective and cost efficient, while providing maximum safety;
  • Examine the scientific literature (found in labeling, drug compendia, and peer reviewed clinical literature) for sound clinical evidence that supports selecting specific drugs to be included on the PDL
  • Ensure that the PDL provides for medically approriate drug therapies for use in the general Medicaid population, allowing healthcare providers to care for the majority of their patients without a prior authorization request.

PREFERRED DRUG LISTS

 

 Effective Date  Posted Date  
  July 17, 2014 July 24, 2014     
  July 1, 2014 June 10, 2014     
  April 1, 2014 March 21, 2014     
  April 1, 2014 February 27, 2014    
  January 1, 2014 December 30,2013     
  January 1, 2014 December 6, 2013    
  August 1, 2013 July 24, 2013
  July 1, 2013 June 19, 2013  
  July 1, 2013 June 3, 2013   
  April 1, 2013 May 29, 2013    
  April 1, 2013  March 26, 2013   
  April 1, 2013  March 4, 2013  
  January 1, 2013  February 26, 2013  
  January 1, 2013  January 11, 2013  
  January 1, 2013  January 3, 2013  
  January 1, 2013 December 10, 2012   
  January 1, 2013   December 7, 2012  
  January 1, 2013 December 5, 2012  
  November 1, 2012 November 1, 2012  
  October 1, 2012  October 1, 2012  
  October 1, 2012 September 26, 2012  
  October 1, 2012  September 7, 2012   
  August 17, 2012 September 26, 2012
  August 17, 2012 September 6, 2012
  July 1, 2012 June 27, 2012
  July 1, 2012 June 6, 2012
  June 11, 2012 June 7, 2012
  May 25, 2012 May 29, 2012
  April 12, 2012 April 17, 2012
  April 1, 2012 March 2, 2012
  January 1, 2012 February 6, 2012
  January 1, 2012 December 2, 2011
  October 1, 2011 October 3, 2011
  October 1, 2011 September 2, 2011
  July 1, 2011 June 10, 2011
  April 1, 2011 Cough/Cold NDC List (update) April 1, 2011
  April 1, 2011 March 25, 2011
  April 1, 2011 March 11, 2011  
  April 1, 2011 March 4, 2011 
  January 1, 2011 February 25, 2011  
  January 1, 2011 December 29, 2010  
  January 1, 2011 December 1, 2010  
  October 1, 2010 October 22, 2010  
  October 1, 2010 September 1, 2010  
  August 10, 2010 August 10, 2010  
  August 1, 2010 July 30, 2010  
  August 1, 2010 Cough/Cold NDC List July 30, 2010    
  July 1, 2010 June 1, 2010  
  April 1, 2010 May 5, 2010  
  April 1, 2010 April 16, 2010  
  April 1, 2010 March 29, 2010  
  April 1, 2010 March 10, 2010  
  January 1, 2010 Vitamin D NDC List December 2, 2009    
  January 1, 2010 December 2, 2009  
  October 1, 2009 September 25, 2009  
  July 1, 2009 June 5, 2009  
  July 1, 2009 Cough/Cold NDC List June 5, 2009    
  July 1, 2009 Prenatal Vitamin NDC List June 5, 2009    
  June 1, 2009 June 5, 2009  
  April 1, 2009 March 5, 2009  
  January 1, 2009 November 26, 2008  
  November 3, 2008 October 20, 2008  
  September 2, 2008 August 29, 2008  
  August 11, 2008 August 8, 2009  (Criteria Changes)  
  July 1, 2008 June 16, 2008  
  April 1, 2008 April 7, 2008  (Criteria Changes)  
  April 1, 2008 March 28, 2008  (Criteria Changes)  
  April 1, 2008 March 4, 2008  
  October 1, 2007 November 13, 2007  (Drug List)  
  October 1, 2007 October 26, 2007  (Drug List)  
  October 1, 2007 October 2, 2007  (Criteria Changes)  
  October 1, 2007 October 1, 2007  (Criteria Changes)  
  October 1, 2007 September 18, 2007  (Drug List)  
  October 1, 2007 September 12, 2007  
  July 9, 2007 August 7, 2007  (Criteria Changes)  
  July 9, 2007 June 25, 2007  (Drug List)  
  April 2, 2007 June 13, 2007  (Drug List)  
  April 2, 2007 March 15, 2007  
  October 2, 2006 March 16, 2007  (Criteria Change)  
  October 2, 2006 January 19, 2007  (Drug List)  
  October 2, 2006 November 20, 2006  (Drug List)  
  October 2, 2006 October 27, 2006  (Criteria Change)   
  October 2, 2006 October 2, 2006  
  April 1, 2006 April 1, 2006  
  October 3, 2005 November 22, 2005  
  October 3, 2005 November 10, 2005  
  July 1, 2005 July 6, 2005  
  July 1, 2005 June 29, 2005  
  July 1, 2005 June 6, 2005  
  April 1, 2004 Phase VIII Tabled  
  April 1, 2004 Phase VIII DUR  
  November 1, 2003 October 29, 2003  
  November 1, 2003 Phase VII  
  August 15, 2003 Phase VI  
  May 1, 2003 Phase V  
  April 9, 2003 Phase IVa  
  April 9, 2003 April 7, 2003  
  March 5, 2003 Phase III  
  February 1, 2003 Phase IV  
  January 13, 2003 Phase I  
  January 7, 2003 March 31, 2003  
  December 1, 2002 Phase II  
Follow us on Facebook